Invention Grant
- Patent Title: Pharmaceutic composition comprising of HDAC inhibitor and a steroid and the use thereof
-
Application No.: US15074768Application Date: 2016-03-18
-
Publication No.: US10143697B2Publication Date: 2018-12-04
- Inventor: Kristina Drott , Thomas Relander
- Applicant: VALCURIA AB
- Applicant Address: SE Lund
- Assignee: VALCURIA AB
- Current Assignee: VALCURIA AB
- Current Assignee Address: SE Lund
- Agency: Stites & Harbison, PLLC
- Agent Stephen J. Weyer, Esq.
- Priority: SE1151196 20111215
- Main IPC: A61K31/573
- IPC: A61K31/573 ; A61K31/167 ; A61K31/165 ; A61K45/06 ; A61K38/07 ; A61K38/12 ; A61K31/18 ; A61K31/19 ; A61K31/404 ; A61K31/437 ; A61K31/4402 ; A61K39/395 ; G01N33/50
Abstract:
A pharmaceutical composition comprises a HDAC inhibitor, a pharmaceutically acceptable acid or a salt thereof or a mixture thereof and a steroid or a pharmaceutically acceptable salt thereof as well use of said pharmaceutical composition for the treatment of cancer as a pretreatment prior to other treatments. Said HDAC inhibitor or steroid may alternatively be administrated separately prior to additional treatments.
Public/Granted literature
- US20160271146A1 PHARMACEUTIC COMPOSITION COMPRISING OF HDAC INHIBITOR AND A STEROID AND THE USE THEREOF Public/Granted day:2016-09-22
Information query
